[1]
A. Hussain, S. et al. 2017. Therapeutic Use of Silymarin in the Management of Suspected Renal and Hepatic Injury Produced by NSAIDs in Osteoarthritis Patients. Iraqi Journal of Pharmaceutical Sciences . 16, 1 (Mar. 2017), 34–38. DOI:https://doi.org/10.31351/vol16iss1pp34-38.